Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
11.66
+0.91 (8.47%)
At close: Nov 21, 2024, 4:00 PM
11.17
-0.49 (-4.19%)
After-hours: Nov 21, 2024, 4:00 PM EST
Avadel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -72.58 | -160.28 | -137.46 | -77.33 | 7.03 | -33.23 | |
| Depreciation & Amortization | 2 | 1.77 | 1.49 | 0.82 | 1.69 | 2.49 | |
| Other Amortization | - | 2.8 | 6.05 | 1.25 | 6.52 | 6 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | -45.76 | 1.75 | |
| Stock-Based Compensation | 19.78 | 15.81 | 7.01 | 8.87 | 3 | 0.52 | |
| Other Operating Activities | 0.56 | 14.39 | 28.07 | -14.61 | -6.89 | -5.37 | |
| Change in Accounts Receivable | -30.86 | -12.1 | - | - | 8.28 | 2.47 | |
| Change in Inventory | -9.5 | -9.53 | - | - | -1.35 | 1.16 | |
| Change in Accounts Payable | -5.81 | 1.55 | -3.11 | 4.23 | -2.79 | 4.64 | |
| Change in Unearned Revenue | - | - | - | - | - | -0.11 | |
| Change in Other Net Operating Assets | 13.61 | 17.09 | 27.64 | -0.54 | -18.47 | -18.64 | |
| Operating Cash Flow | -82.81 | -128.51 | -70.3 | -77.31 | -48.73 | -38.33 | |
| Capital Expenditures | - | - | -0.72 | -0.03 | -0.1 | -0.03 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.15 | |
| Divestitures | - | - | - | 16.5 | 25.5 | - | |
| Investment in Securities | 64.8 | -50.09 | 80.41 | 40.46 | -95.12 | 38.6 | |
| Investing Cash Flow | 64.8 | -50.09 | 79.7 | 56.93 | -69.72 | 38.72 | |
| Long-Term Debt Repaid | - | -38.67 | -8.65 | - | - | - | |
| Net Debt Issued (Repaid) | -21.17 | -38.67 | -8.65 | - | - | - | |
| Issuance of Common Stock | 15.14 | 148.36 | 28 | 0.26 | 179.68 | 0.12 | |
| Other Financing Activities | - | 25.64 | -4.8 | - | - | -0.15 | |
| Financing Cash Flow | -6.02 | 135.34 | 14.54 | 0.26 | 179.68 | -0.03 | |
| Foreign Exchange Rate Adjustments | 0.81 | 0.46 | -0.66 | -0.9 | 0.72 | 0.08 | |
| Net Cash Flow | -23.23 | -42.81 | 23.27 | -21.01 | 61.95 | 0.45 | |
| Free Cash Flow | -82.81 | -128.51 | -71.02 | -77.34 | -48.83 | -38.35 | |
| Free Cash Flow Margin | -59.94% | -459.58% | - | - | -218.64% | -64.77% | |
| Free Cash Flow Per Share | -0.89 | -1.60 | -1.18 | -1.32 | -0.89 | -1.03 | |
| Cash Interest Paid | 4.04 | 5.25 | 9.66 | 6.47 | 6.47 | 6.47 | |
| Cash Income Tax Paid | - | - | -29.06 | 0.08 | -1.7 | 0.14 | |
| Levered Free Cash Flow | -58.92 | -78.68 | -25.39 | -38.03 | -57.42 | -14.48 | |
| Unlevered Free Cash Flow | -52.37 | -75.3 | -23.73 | -33.07 | -55.83 | -12.67 | |
| Change in Net Working Capital | 34.14 | 6.72 | -27.99 | -10.77 | 37.5 | 5.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.